Decision-making tree model for distinguishing between benign and malignant subpleural pulmonary lesions based on ultrasonic strain elastography

IF 4.4 2区 医学 Q1 ONCOLOGY Lung Cancer Pub Date : 2025-04-18 DOI:10.1016/j.lungcan.2025.108547
Kaiwen Wu , Ke Bi , Mengjun Shen, Chunhong Tang, Yin Wang
{"title":"Decision-making tree model for distinguishing between benign and malignant subpleural pulmonary lesions based on ultrasonic strain elastography","authors":"Kaiwen Wu ,&nbsp;Ke Bi ,&nbsp;Mengjun Shen,&nbsp;Chunhong Tang,&nbsp;Yin Wang","doi":"10.1016/j.lungcan.2025.108547","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To evaluate ultrasonic strain elastography (USE) findings of subpleural pulmonary lesions (SPLs) and generate a decision-making tree model to distinguish between benign and malignant SPLs.</div></div><div><h3>Methods</h3><div>We prospectively analyzed the USE findings in patients with SPLs from May 2020 to June 2021. The findings included the strain ratio of the lesion (including non-perfusion areas) to the chest wall muscle (referred to as SRI), the strain ratio of the lesion (excluding non-perfusion areas) to the chest wall muscle (referred to as SRE), and the water ripple sign. The patients were divided into a development cohort (DC) and a validation cohort (VC). Using the DC, we employed conditional inference tree analysis to generate a decision-making tree model based on the USE findings. The diagnostic performances of the models were evaluated using the VC.</div></div><div><h3>Results</h3><div>In total, 353 patients were eligible: 247 in the DC and 106 in the VC group. The SRI, SRE, and water ripple sign were good discriminators between benign and malignant SPLs. The model employing the SRI (with a cut-off of 11.6) showed 92.16% sensitivity, 81.82% specificity and 86.79% accuracy, whereas the model employing the SRE (with a cut-off of 11.6) achieved 94.12% sensitivity, 85.46% specificity and 89.62% accuracy.</div></div><div><h3>Conclusions</h3><div>The decision-making tree model based on USE effectively distinguished between benign and malignant SPLs. We suggest that the SRI or SRE be evaluated first and the water ripple sign should be evaluated subsequently in cases where the SRI or SRE exceeds 11.6.</div></div>","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"203 ","pages":"Article 108547"},"PeriodicalIF":4.4000,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500225004398","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

To evaluate ultrasonic strain elastography (USE) findings of subpleural pulmonary lesions (SPLs) and generate a decision-making tree model to distinguish between benign and malignant SPLs.

Methods

We prospectively analyzed the USE findings in patients with SPLs from May 2020 to June 2021. The findings included the strain ratio of the lesion (including non-perfusion areas) to the chest wall muscle (referred to as SRI), the strain ratio of the lesion (excluding non-perfusion areas) to the chest wall muscle (referred to as SRE), and the water ripple sign. The patients were divided into a development cohort (DC) and a validation cohort (VC). Using the DC, we employed conditional inference tree analysis to generate a decision-making tree model based on the USE findings. The diagnostic performances of the models were evaluated using the VC.

Results

In total, 353 patients were eligible: 247 in the DC and 106 in the VC group. The SRI, SRE, and water ripple sign were good discriminators between benign and malignant SPLs. The model employing the SRI (with a cut-off of 11.6) showed 92.16% sensitivity, 81.82% specificity and 86.79% accuracy, whereas the model employing the SRE (with a cut-off of 11.6) achieved 94.12% sensitivity, 85.46% specificity and 89.62% accuracy.

Conclusions

The decision-making tree model based on USE effectively distinguished between benign and malignant SPLs. We suggest that the SRI or SRE be evaluated first and the water ripple sign should be evaluated subsequently in cases where the SRI or SRE exceeds 11.6.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于超声应变弹性成像的胸膜下肺良恶性区分决策树模型
目的评价超声应变弹性成像(USE)在胸膜下肺病变(SPLs)中的表现,并建立决策树模型来区分胸膜下肺病变的良恶性。方法前瞻性分析2020年5月至2021年6月SPLs患者的USE结果。结果包括病变(包括非灌注区)与胸壁肌肉的应变比(简称SRI)、病变(不包括非灌注区)与胸壁肌肉的应变比(简称SRE)、水纹征。患者被分为发展队列(DC)和验证队列(VC)。使用DC,我们采用条件推理树分析来生成基于USE发现的决策树模型。利用VC对模型的诊断性能进行了评价。结果共纳入353例患者:DC组247例,VC组106例。SRI、SRE和水纹征是良性和恶性SPLs的良好鉴别指标。采用SRI(截止值为11.6)的模型灵敏度为92.16%,特异性为81.82%,准确度为86.79%,而采用SRE(截止值为11.6)的模型灵敏度为94.12%,特异性为85.46%,准确度为89.62%。结论基于USE的决策树模型能有效区分恶性和良恶性SPLs。我们建议先评估SRI或SRE,当SRI或SRE超过11.6时,再评估水纹符号。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Lung Cancer
Lung Cancer 医学-呼吸系统
CiteScore
9.40
自引率
3.80%
发文量
407
审稿时长
25 days
期刊介绍: Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.
期刊最新文献
Locoregional therapies in advanced and recurrent pleural mesothelioma: A systematic review Neoadjuvant immunotherapy plus chemotherapy in locally advanced stage III NSCLC patients undergoing definitive chemo-radiotherapy---a real‑world multicenter retrospective study Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840]. A pathomics model for predicting response to chemo-immunotherapy in lung squamous cell carcinoma: A multicenter study Identifying eligible patients for the Australian national lung cancer screening program in primary care: A cross-sectional study using clinical decision support systems and evaluating PLCOm2012 data quality
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1